Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center-Reference-Cited by-同舟云学术

Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center

Published:2017-06 Issue: Volume:69 Page:26-32
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Wu Li-Rong,Liu Ya-Tian,Jiang Ning,Fan Yan-Xin,Wen Jing,Huang Sheng-Fu,Guo Wen-Jie,Bian Xiu-Hua,Wang Fei-Jiang,Li Feng,Song Dan,Wu Jian-Feng,Jiang Xue-Song,Liu Ju-Ying,He Xia

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference32 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;International Journal of Cancer,2015

2. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients;Baujat;International Journal of Radiation Oncology Biology Physics,2006

3. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma;Ma;Expert Review of Anticancer Therapy,2006

4. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial;Chen;Lancet Oncol,2012

5. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099;Al-Sarraf;Journal of Clinical Oncology,1998

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Compared with High-Dose Regimen of Induction Chemotherapy in Locally Advanced Nasopharyngeal Cancer: A Systematic Review and Meta-analysis;South Asian Journal of Cancer;2024-08-23

2. Prognostic significance of platelet‑to‑albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases;BMC Cancer;2024-06-25

3. Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma;BMC Cancer;2024-05-27

4. The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis;Cancer Immunology, Immunotherapy;2024-05-11

5. Examining patient-reported late toxicity and its association with quality of life and unmet need for symptom management among nasopharyngeal cancer survivors: a cross-sectional survey;Frontiers in Oncology;2024-04-17